|
業務類別
|
Biotechnology |
|
業務概覽
|
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue. |
| 公司地址
| 100 Marine Parkway, Suite 400, Redwood City, CA, USA, 94065 |
| 電話號碼
| +1 650 213-8444 |
| 傳真號碼
| +1 650 213-8383 |
| 公司網頁
| https://www.soleno.life |
| 員工數量
| 92 |
| Dr. Michael Huang, M.D. |
Senior Vice President, Clinical Development |
-- |
22/04/2025 |
| Ms. Patricia C. Hirano |
Senior Vice President, Regulatory Affairs |
美元 375.00K |
22/04/2025 |
| Ms. Meredith S. Manning |
Chief Commercial Officer |
美元 415.18K |
22/04/2025 |
| Ms. Jennifer Fulk |
Chief Financial Officer |
-- |
26/02/2026 |
| Ms. Kristen Yen |
Senior Vice President, Global Clinical Operations and Patient Advocacy |
-- |
22/04/2025 |
| Dr. Anish Bhatnagar, M.D. |
President, Chief Executive Officer and Chairman of the Board |
美元 640.00K |
26/02/2026 |
|
|
| Mr. Matthew Pauls, J.D.,M.B.A. |
Lead Independent Director |
25/02/2026 |
| Dr. Birgitte Volck, M.D.,PhD |
Independent Director |
25/02/2026 |
| Dr. Andrew Sinclair, PhD |
Independent Director |
25/02/2026 |
| Dr. Anish Bhatnagar, M.D. |
President, Chief Executive Officer and Chairman of the Board |
26/02/2026 |
| Mr. Mark W. Hahn |
Independent Director |
25/02/2026 |
| Mr. William G. Harris |
Independent Director |
22/04/2025 |
| Ms. Dawn Carter Bir |
Director |
25/02/2026 |
|
|
|
|
